Healthcare Regulation and Compliance CLE Courses | Online CLE

From Rookie to Ready: Handling Your First FDA-Regulated Case

Beginner

Handling your first healthcare law case involving FDA regulation can be daunting, but this course will provide the key insights and strategies you need to succeed. In this CLE, we will walk through the essentials of FDA law, including regulatory frameworks, enforcement risks, and best practices for client representation. Presented in a podcast-style discussion, this session will cover practical approaches to issue-spotting, compliance challenges, and advocacy strategies in FDA-regulated...

View More Details

Bridge the Gap: NY Newly Admitted CLE

Complete your mandatory New York newly admitted attorney live CLE requirements in just two days with our comprehensive Bridge the Gap program. Live, interactive, and designed specifically for your needs. What’s Included? ☑️ 9 Hours of Required Live CLE Credits ☑️ 6 hours of Skills credits ☑️ 3 hours of Ethics credits ☑️ Fully compliant with NY CLE Board requirements See agenda below! Who Should Attend This Event? New York Newly Admitted attorneys seeking to complete their Live...

View More Details

Dissecting the 2025 Proposed HIPAA Security Rule: Refresh, Rewrite or Revolution?

1h•Intermediate

Practice Areas,

Technology,

Healthcare,

Healthcare Providers,

Healthcare Regulation and Compliance,

Privacy & Cybersecurity,

Data Security,

Privacy & Cybersecurity Regulation and Compliance,

Biometric Data,

Technology in the Law

In the waning days of 2024 (and the Biden Administration) the HHS Office of Civil Rights announced a new proposed rule that would significantly rewrite the HIPAA Security Rule. The proposed rule strengthens existing regulations and brings them up to date with modern technologies. OCR also expressly designed the rule to deal with new threats to cybersecurity in the healthcare industry. This program will introduce students and participants to the major changes contained in the...

View More Details

Transactional and Operational Insights on (Showstopping) Healthcare Due Diligence & Paths to Preventing Death to a Deal

1h 1m•Intermediate

Practice Areas,

Corporate & Securities,

Corporate Contracts,

Mergers & Acquisitions,

Transactional Analysis,

Deal Structures Overview & Mechanics,

Healthcare,

Healthcare Regulation and Compliance

Over the course of their careers, the panelists have shepherded healthcare clients through the due diligence process involved in strategic corporate transactions and have some great (horror) stories and hard lessons learned to share with the audience! One panelist will share her perspective as a transactional health lawyer on how to advise clients on the business risks that arise from due diligence through crafting definitive agreement mechanisms to best protect against unwanted liabilities...

View More Details

Private Equity in Healthcare: Challenges, Pitfalls and Opportunities

1h 9m•Intermediate

Practice Areas,

Corporate & Securities,

Corporate Contracts,

Corporate Restructuring,

Equity Instruments,

Banking & Financial Services,

Financing,

Banking & Financial Services Regulation and Compliance,

Healthcare,

Healthcare Providers,

Healthcare Regulation and Compliance

This course, presented by Adam Laughton, will walk attorneys, physicians, and managers through the process of an acquisition of a medical practice, facility, or healthcare business by private equity. We will discuss steps to prepare sellers for the transaction and steps that sellers can take to protect themselves. We will also discuss the ongoing process of working under private equity ownership, as well as some common criticisms of increasing private equity investment in the industry,...

View More Details

DEI in Healthcare: Turning a Heavy Topic into a Manageable Lift

1h 5m•Beginner

DEI,

Elimination of Bias,

Race,

Practice Areas,

Healthcare,

Healthcare Providers,

Public Health,

Healthcare Regulation and Compliance

The value of diversity has been researched extensively for its impact on various industries, including the healthcare industry. Like other industries, the value of diversity in healthcare includes improved problem-solving, employee recruitment and retention, and profitability. However, there are additional, critical implications in the healthcare industry including improved patient outcomes and population health, reduced healthcare disparities, expanded research protocols, and...

View More Details

Regulatory Realities: A Guide to Success for Early Careerists on Hospital Deal Teams

1h 3m•Advanced

Practice Areas,

Corporate & Securities,

Corporate Contracts,

Healthcare,

Healthcare Regulation and Compliance

Strategic corporate transactions that involve hospitals and health systems are subject to a plethora of federal, state, and local laws and regulations. The high level of governmental oversight requires that hospital/health system transactions have separate signings and closings to allow sufficient time for the parties to accommodate the many filings, notices, consents, and other governmental approvals that are necessary to close the transaction as well as operate the business effectively...

View More Details

Section 1557 of the Affordable Care Act: A Guide to the Final Rule

1h 3m•Intermediate

Healthcare Regulation and Compliance,

Public Benefits

Section 1557 of the Affordable Care Act (Section 1557) prohibits discrimination on the basis of race, color, national origin, age, disability, or sex (including pregnancy, sexual orientation, gender identity, and sex characteristics), in covered, HHS-subsidized health programs or activities. See 42 U.S.C. §18116 et seq. On Friday, HHS released the long-awaited the Section 1557 final rule, which becomes law 60 days after Federal Register publication. There is much to consider in the final rule,...

View More Details

Spotlight on Life Sciences: U.S. Growing Interest and Scrutiny in the Life Sciences Space - the FTC, PTO and NIH

1h 3m•Intermediate

Practice Areas,

Intellectual Property,

Patent,

Life Sciences Regulation and Compliance,

Healthcare,

Healthcare Regulation and Compliance

This presentation by Brian Coggio and Kelly Del Dotto summarizes the efforts of various agencies of the U.S. government - the FTC, PTO, and NIH - to investigate, monitor, and indeed control the life science industry. In particular, the FTC is monitoring Orange Book listings; the PTO is requiring patentees to ensure that statements to the PTO and other agencies are consistent with one another; and the NIH is threatening to use march-in rights to control drug prices. It is crucial that members of...

View More Details

Preventing Medical Errors: Best Practices for Advance Directives & Living Wills

1h 5m•Intermediate

Practice Areas,

Healthcare,

Healthcare Regulation and Compliance

This program will help attorneys understand best practices for advance healthcare directives and living wills during a pandemic situation. Attorneys will learn: (1) how to identify common issues when creating advance directives, (2) the risk of wrongful prolongation of life claims (3) when to advise clients and families to discuss their options with medical teams, and (4) proper use of Portable Orders for Life-Sustaining Treatment (POLST) forms. The course will also discuss the use of...